Why can't we make an effective vaccine against Helicobacter pylori?

By Sutton Philip   Chionh Yok Teng  

Expert Review of Vaccines, Vol. 12, Iss. 4, 2013-04 ,pp. : 433-441

Informa Healthcare

Access to resources Recommend Favorite

Epitope-vaccine strategy against HIV-1: today and tomorrow

By Liu Zuqiang   Xiao Yi   Chen Ying-Hua  

Immunobiology, Vol. 208, Iss. 4, 2003-12 ,pp. : 423-428

Urban & Fischer

Access to resources Recommend Favorite

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

By Clarke David   Cooper David   Egan Michael   Hendry R.   Parks Christopher   Udem Stephen  

Springer Seminars in Immunopathology, Vol. 28, Iss. 3, 2006-11 ,pp. : 239-253

Springer Publishing Company

Access to resources Recommend Favorite

Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine

By Pisarev V.M.   Parajuli P.   Mosley R.L.   Sublet J.   Kelsey L.   Sarin P.S.   Zimmerman D.H.   Winship M.D.   Talmadge J.E.  

International Journal of Immunopharmacology, Vol. 22, Iss. 11, 2000-11 ,pp. : 865-876

Elsevier

Access to resources Recommend Favorite

Vaccine development against HIV-1: Current perspectives and future directions

By Edgeworth Rebecca   Juan Homero   Rosenzweig Jason   Nguyen Nang   Boyer Jean   Ugen Kenneth  

Immunologic Research, Vol. 25, Iss. 1, 2002-02 ,pp. : 53-74

Humana Press, Inc

Access to resources Recommend Favorite